Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The mitochondrial protease LonP1 promotes proteasome inhibitor resistance in multiple myeloma.
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Transcriptomic profiling of drug-naïve or proteasome inhibitor-resistant myeloma cell lines
PubMed Full text in PMC Similar studies SRA Run Selector
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes in Multiple Myeloma (MM) cell lines treated with DMSO and Indirubin-3’-monoxime (I3MO)
PubMed Full text in PMC Similar studies Analyze with GEO2R
Deacetylation of HP1g enhances multiple myeloma drug resistance through DNA damage repair and liquid-liquid phase separation (ChIP-seq)
PubMed Full text in PMC Similar studies
Deacetylation of HP1g enhances multiple myeloma drug resistance through DNA damage repair and liquid-liquid phase separation
Deacetylation of HP1g enhances multiple myeloma drug resistance through DNA damage repair and liquid-liquid phase separation (RNA-Seq)
Deacetylation of HP1g enhances multiple myeloma drug resistance through DNA damage repair and liquid-liquid phase separation (ATAC-Seq)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on